MedTrace Logo

Locally Produced Cloth Face Mask and COVID-19 Like Illness Prevention

NCT04471766 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40000

Last updated 2021-10-13

No results posted yet for this study

Summary

The number of cases of COVID-19 is still increasing and transmission of SARS-CoV-2 seems to occur mainly through person-to-person transmission through respiratory droplets, indirect contact with infected people and surfaces. The use of face masks is recommended as a public health measure, but in many settings only domestic cloth made masks are available to the majority of the people. However, masks can be of different quality and very little is known about the utility of cloth face masks at the community level.

In Bandim Health Project's Health and Demographic Surveillance System we will evaluate the effect of providing locally produced cloth face masks on severity of COVID-19 like illness and mortality in an urban population. The locally produced cloth mask is made according to a laboratory certified model and will be provided to the intervention group alongside information of how the risk of transmission can be reduced. The control group will receive information alone.

Follow-up will be implemented through telephone calls and post-epidemic home visits.

Conditions

Interventions

OTHER

Certified cloth face mask plus preventive information

Provision of two face masks sewed locally following a certified model tested for FORCE in the laboratory per residents \> 10 years old

BEHAVIORAL

Preventive information

Advice on how to prevent COVID-19 according to the government´ policy

Sponsors & Collaborators

  • University of Southern Denmark

    collaborator OTHER

  • Engineers without Borders, Denmark (https://iug.dk/en)

    collaborator UNKNOWN

  • Bandim Health Project

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2021-10-31
Completion
2021-10-31

Countries

  • Guinea-Bissau

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04471766 on ClinicalTrials.gov